This is a bizarre critique Kurt. The company has never suggested it would take a cholesterol drug through stage 3 trials, but rather as an early drug development company. Their main misstep was doing some business in China which led to delays during Covid but they've managed their capital and this announcement is progress consistent with recent updates.
I'm confused why this wasn't deeme price sensitive
NYR Price at posting:
8.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)